Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle

Current Opinion in Cell Biology

Volumn 12, Issue 6, 2000, Pages 676-684

  Ekholm, Susanna V ^a   Reed, Steven I ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0033711708     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00151-4     Document Type: Review

References (105)

1. Cyclins and their partners: From a simple idea to complicated reality
2. The role of p34 kinases in the G1 to S-phase transition
3. Animal cell cycles and their control
4. Activation of the various cyclin/cdc2 protein kinases
5. G1 phase progression: Cycling on cue
6. Principles of CDK regulation
7. Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle
8. Cyclins and cyclin-dependent kinases: A biochemical view
9. Control of the G1/S transition
10. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors
11. Cyclin-dependent kinases: Inhibition and substrate recognition
12. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWl/SNF and Rb-hSWl/SNF
13. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
14. Mammalian G1 cyclins
15. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
16. Cyclin-dependent regulation of G1 in mammalian fibroblasts
17. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
18. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
19. Mammalian G1 cyclins
20. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
21. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
22. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21 (Cip1)
23. Direct induction of cyclin D2 by Myc contributes to ceil cycle progression and sequestration of p27
24. Inducible regulatory elements in the human cyclin D1 promoter
25. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
26. Cell-cycle-dependent variations in c-Jun and Jun B phosphorylation: A role in the control of cyclin D1 expression
27. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
28. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1 -to-S-phase transition
29. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1
30. The role of cyclin E in cell proliferation, development and cancer
31. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex
32. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway
33. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts
34. The mRNA 5' cap-binding protein elF4E and control of cell growth
35. 2+ stores, phosphorylation of elF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole
36. Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression
37. Proteolysis and the cell cycle: With this RING I do thee destroy
38. Proteolysis and the G1-S transition: The SCF connection
39. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
40. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286
41. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation
42. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E
43. Deletion of the Cull gene in mice causes arrest in early embryogenesis and accumulation of cyclin E
44. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E
45. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells
46. Maturation of human cyclin E requires the function of eukaryotic chaperonin CCT
47. D-type cyclin-dependent kinase activity in mammalian cells
48. Interaction between Cdc37 and Cdk4 in human cells
49. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
50. CDK inhibitors: Positive and negative regulators of G1 -phase progression
51. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells
52. Cell-cycle inhibitors: Three families united by a common cause
53. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
54. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-cdk2 and cyclin D2-cdk4
55. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
56. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d
57. WAF1, a potential mediator of p53 tumor suppression
58. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases
59. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
60. Mice lacking p21ClP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
61. Radiation-induced cell cycle arrest compromised by p21 deficiency
62. p53-dependent elevation of p21waf1 expression by UV light is mediated through mRna stabilization and involves a vanadate-sensitive regulatory system
63. p53-dependent and independent expression of p21 during cell growth, differentiation, and Dna damage
64. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells
65. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
66. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
67. p21(Cip1) and p57(Kip2) control muscle differentiation at the myogenin step
68. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome
69. Transcriptional control by the TGF-beta/Smad signaling system
70. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p151NK4B through an Spl consensus site
71. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines
72. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15
73. The ARF/p53 pathway
74. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation
75. Inactivation of p16 in human mammary epithelial cells by CpG island methylation
76. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest
77. Genes involved in melanoma: An overview of INK4a and other loci
78. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression
79. Differential regulation of the AP-1 family members by UV irradiation in vitro and in vivo
80. Ultraviolet radiation induces p16CDKN2A expression in human skin
81. Translational control of p27Kip1 accumulation during the cell cycle
82. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest
83. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter
84. Molecular cloning and characterization of the human p27Kip1 gene promoter
85. Two short sequences have positive effects on the human p27Kipl gene transcription
86. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements
87. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms
88. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
89. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
90. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on Cdk2 activity and the proteasome
91. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): Evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway
92. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle
93. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
94. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity
95. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
96. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression
97. Induction of p21 (WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)
98. New functional activities for the p21 family of CDK inhibitors
99. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
100. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
101. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
102. Rapid destruction of human Cdc25A in response to DNA damage
103. Cell cycle start from quiescence controlled by tyrosine phosphorylation of Cdk4
104. Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest
105. Proteasomal turnoverof p21Cip1 does not require p21Cip1 ubiquitination